Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Horm Metab Res ; 45(5): 338-43, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23322513

RESUMEN

We have previously reported that intrarenal angiotensin II (Ang II) levels are increased long before diabetes becomes apparent in obese Otsuka-Long-Evans-Tokushima-Fatty (OLETF) rats, a model of type 2 diabetes. In this study, we examined the changes in intrarenal renin-angiotensin system (RAS) activity in the developing kidneys of OLETF rats. Ang II contents and mRNA levels of RAS components were measured in male OLETF and control Long-Evans Tokushima (LETO) rats at postnatal days (PND) 1, 5, and 15, and at 4-30 weeks of age. In both LETO and OLETF rats, kidney Ang II levels peaked at PND 1, then decreased during the pre- and post-weaning periods. However, Ang II levels and gene expression of RAS components, including angiotensinogen (AGT), renin, and angiotensin-converting enzyme (ACE), were not significantly different between LETO and OLETF rats. Intrarenal Ang IIcontents further decreased during puberty (from 7 to 11 weeks of age) in LETO rats, bur not in OLETF rats. At 11 weeks of age, kidney Ang II levels, urinary AGT excretion, and mRNA levels of AGT and renin were higher in OLETF rats than in LETO rats, while blood glucose levels were not significantly different between these groups of rats. These data indicate that continued intrarenal expression of Ang II during pubescence contributes to the increases in intrarenal Ang II levels in prediabetic OLETF rats, and is associated with increased intrarenal AGT and renin expression. Inappropriate activation of the intrarenal RAS in the prediabetic stage may facilitate the onset and development of diabetic nephropathy in later life.


Asunto(s)
Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Riñón/crecimiento & desarrollo , Riñón/metabolismo , Sistema Renina-Angiotensina , Albuminuria/complicaciones , Angiotensina II/metabolismo , Angiotensinógeno/metabolismo , Animales , Glucemia/metabolismo , Presión Sanguínea , Peso Corporal , Colágeno/genética , Colágeno/metabolismo , Factor de Crecimiento del Tejido Conjuntivo/genética , Factor de Crecimiento del Tejido Conjuntivo/metabolismo , Creatinina/orina , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/genética , Diabetes Mellitus Experimental/orina , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/genética , Diabetes Mellitus Tipo 2/orina , Femenino , Regulación de la Expresión Génica , Tamaño de los Órganos , Peptidil-Dipeptidasa A/metabolismo , Ratas , Ratas Endogámicas OLETF , Receptores de Angiotensina/metabolismo , Renina/metabolismo , Factores de Tiempo , Factor de Crecimiento Transformador beta/genética , Factor de Crecimiento Transformador beta/metabolismo
3.
Am J Vet Res ; 40(1): 111-4, 1979 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-453672

RESUMEN

The skin of 15 hairless newborn pigs with parenchymatous goiter was studied histopathologically. Most of the lesions were in the hair follicles; follicles were scarce and reduced in size, contained slender hairs, and revealed a shortage of penetration into the hypodermis. Hair follicles in the immature stages, hair pegs, and germs also were recognized, with the thin epidermis lacking in keratinization. It was felt that these changes resulted from a retardation of cellular differentiation of the germinal layer. In view of these findings, skin lesions were regarded as hypoplasia of hair.


Asunto(s)
Animales Recién Nacidos , Bocio/veterinaria , Cabello/patología , Piel/patología , Enfermedades de los Porcinos/patología , Animales , Femenino , Bocio/patología , Masculino , Enfermedades de la Piel/patología , Enfermedades de la Piel/veterinaria , Porcinos
6.
Nihon Yakurigaku Zasshi ; 113(3): 145-56, 1999 Mar.
Artículo en Japonés | MEDLINE | ID: mdl-10347839

RESUMEN

Propiverine is a drug for the treatment of incontinence and pollakiuria. The effects of propiverine on isolated rat and dog urinary bladder were investigated. At doses of 10(-6)-3 x 10(-5) M, propiverine caused both a rightward shift and inhibition of the maximum response in the acetylcholine (ACh) dose-response curve. The pA2 values for rat and dog urinary bladder were 5.97 and 6.62, respectively. At doses of 10(-5)-10(-5) M, propiverine also dose-dependently inhibited KCl (100 mM)-induced contractions. The IC50 values for rat and dog urinary bladder were 3.9 x 10(-6) M and 3.8 x 10(-6) M, respectively. The pA2 value and the IC50 value of terodiline for rat urinary bladder were 6.08 and 6.6 x 10(-6) M, respectively. In contrast, the pA2 value and the IC50 value of oxybutynin for rat urinary bladder were 7.69 and 4.5 x 10(-6) M, respectively, suggesting that oxybutynin exerts an anti-muscarinic effect at doses at which no discernible anti-KCl effect was observed, whereas propiverine and terodiline exerted both effects at the same doses. The inhibitory effect of drugs on the contraction induced by electrical field stimulation was tested. At a dose of 10(-7) g/ml, tetrodotoxin inhibited the contraction of rat and dog urinary bladder by 76.6% and 92.6%, respectively. Propiverine and verapamil dose-dependently inhibited the contractile response induced by electrical field stimulation at doses of 10(-5) M or more and 3 x 10(-6) M or more, respectively. At these concentrations, a marked anti-KCl effect of the drugs on smooth muscle was observed. On the other hand, atropine caused no inhibition of the contractile response in rat urinary bladder at a dose of 3 x 10(-5) M, and it inhibited the contraction in dog urinary bladder by 14.9% at a dose of 10(-5) M. These findings suggest that although propiverine exhibits both anti-muscarinic and anti-KCl effects in isolated rat and dog urinary bladder, the inhibitory effects of propiverine on the atropine-resistant part of contraction may be mainly due to its anti-KCl effect.


Asunto(s)
Bencilatos/farmacología , Parasimpatolíticos/farmacología , Vejiga Urinaria/efectos de los fármacos , Acetilcolina/antagonistas & inhibidores , Animales , Atropina/farmacología , Butilaminas/farmacología , Perros , Relación Dosis-Respuesta a Droga , Estimulación Eléctrica , Femenino , Técnicas In Vitro , Masculino , Ácidos Mandélicos/farmacología , Antagonistas Muscarínicos/farmacología , Contracción Muscular/efectos de los fármacos , Cloruro de Potasio/antagonistas & inhibidores , Propantelina/farmacología , Ratas , Ratas Wistar , Micción/efectos de los fármacos , Trastornos Urinarios/tratamiento farmacológico , Vasodilatadores/antagonistas & inhibidores , Verapamilo/farmacología
7.
J Org Chem ; 66(2): 557-63, 2001 Jan 26.
Artículo en Inglés | MEDLINE | ID: mdl-11429829

RESUMEN

Derivatives of optically active 1,12-dimethylbenzo[c]phenanthrene-5,8-dicarboxylic acid can be nitrated regioselectively, giving symmetrically polyfunctionalized helicenes. The dicarboxylic acid or its dimethyl ester is dinitrated with fuming nitric acid in acetic acid at the 4,9-positions. When the reaction is conducted in fuming nitric acid, a 2,4,9,11-tetranitrohelicene is obtained. Analogously, 1,12-dimethylbenzo[c]phenanthrene-5,8-dinitrile gives 2,11-dinitro- or 4,9-dinitrohelicene depending on the conditions, and the former compound is converted to a 2,4,9,11-tetranitrohelicene. The tetranitrohelicenes form charge-transfer (CT) complexes with an electron-rich chiral diaminohelicene in solution. The studies on the chiral recognition reveal that the combinations of the same configuration of the helicenes form more stable complexes than that of the enantiomeric helicenes.

8.
Nihon Yakurigaku Zasshi ; 91(4): 221-36, 1988 Apr.
Artículo en Japonés | MEDLINE | ID: mdl-3391446

RESUMEN

The general pharmacological effects of cadralazine and its major metabolite ISF 2405 were studied by comparing them with those of hydralazine. Cadralazine at 3.0 mg/kg, i.v., increased respiratory movement and heart rate and decreased blood pressure in cats. Cadralazine at 3.0 mg/kg, i.v., inhibited the hypertensive response induced by adrenaline, but showed little effect on the hypotensive response induced by acetylcholine in cats. Cadralazine and ISF 2405 at 10(-4) g/ml had negative chronotropic effects on isolated guinea-pig atria. The drug at 2.5 mg/kg, p.o., inhibited the passage of BaSO4 in the gastrointestinal tract in mice. The drug at 5.0 mg/kg, i.d. or more inhibited gastric secretion in rats. Cadralazine, except at higher doses, had little effect on spontaneous gastric motility and uterine spontaneous movement in rats. Cadralazine at 2.5 mg/kg, p.o., or more reduced or tended to reduce urine volume and urinary excretion of electrolytes. The drug showed little effect on coagulation and osmotic fragility in blood cell in rats nor on hemolysis and platelet aggregation in rabbits. ISF 2405, however, showed slight or moderate influence on hemolysis at concentrations as high as 0.01-1.0%. Cadralazine at 5.0 mg/kg, p.o. or more antagonized carrageenin-induced hind paw edema in rats. In conclusion, these effects of cadralazine were found to be qualitatively identical with those of hydralazine.


Asunto(s)
Circulación Sanguínea/efectos de los fármacos , Piridazinas/farmacología , Respiración/efectos de los fármacos , Animales , Sistema Nervioso Autónomo/efectos de los fármacos , Gatos , Sistema Digestivo/efectos de los fármacos , Femenino , Cobayas , Hidralazina/farmacología , Riñón/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos ICR , Ratones Endogámicos , Conejos , Ratas , Ratas Endogámicas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA